Literature DB >> 26238634

Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors.

Sharon R Rosenberg1, Ravi Kalhan1, David M Mannino2.   

Abstract

Chronic obstructive pulmonary disease (COPD) remains a common and important cause of morbidity and mortality both in the United States and globally. The increasing trends of COPD prevalence, morbidity, and mortality seen in the later part of last century have not continued in the United States. COPD prevalence, hospitalizations, and deaths have remained stable or are decreasing over the last decade. This is likely a function of the overall decreasing prevalence of tobacco use over the past 50 years, along with improved therapies for COPD. Future trends in COPD will probably be driven by factors in addition to tobacco use, such as longer survival in the population, other occupational and environmental exposures, and the increasing prevalence of asthma. Globally, factors such as air pollution and chronic respiratory infections, such as tuberculosis, will remain important predictors of future trends. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26238634     DOI: 10.1055/s-0035-1555607

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  28 in total

1.  Sensor technology: a critical cutting edge of exposure science.

Authors:  Richard E Peltier; Timothy J Buckley
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-09-23       Impact factor: 5.563

Review 2.  Effects of melatonin on protecting against lung injury (Review).

Authors:  Weiwei Wang; Ju Gao
Journal:  Exp Ther Med       Date:  2021-01-20       Impact factor: 2.447

3.  BMI moderates the association between adverse childhood experiences and COPD.

Authors:  Megan R Westmore; Priyanjali Chakraborty; LaTisha A Thomas; Lacey Jenkins; Faheem Ohri; Philip Baiden
Journal:  J Psychosom Res       Date:  2022-07-16       Impact factor: 4.620

4.  Evaluating a Pharmacist-Initiated Care Bundle for Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jacqueline Kwok; Michael Kammermayer; Vincent H Mabasa; Tiffany Winstone; Darwin Chan
Journal:  Can J Hosp Pharm       Date:  2022-10-03

5.  Comorbid Chronic Obstructive Pulmonary Disease and Heart Failure: Shared Risk Factors and Opportunities to Improve Outcomes.

Authors:  Sadiya S Khan; Ravi Kalhan
Journal:  Ann Am Thorac Soc       Date:  2022-06

6.  Effectiveness and safety of acupoint application for chronic obstructive pulmonary disease: A protocol for updated systematic review and meta-analysis.

Authors:  Hao-Yang Zhang; Han Huang; Li-Jian Pang; Xiao-Dong Lv; Wei-Dong Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

7.  Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol.

Authors:  Almaz Sharman; Baurzhan Zhussupov; Dana Sharman; Assel Stambekova; Sattar Yeraliyev
Journal:  JMIR Res Protoc       Date:  2017-07-25

Review 8.  Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.

Authors:  Manish Bodas; Neeraj Vij
Journal:  Respir Res       Date:  2017-05-04

9.  Wellbeing and chronic lung disease incidence: The Survey of Health, Ageing and Retirement in Europe.

Authors:  Judith A Okely; Seif O Shaheen; Alexander Weiss; Catharine R Gale
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

10.  Critical regulation of inflammation via class A scavenger receptor.

Authors:  Liang Xie; Qingmin Li; Ran Dong; Kaishun Zhao; Yun Feng; Zhiyao Bao; Min Zhou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.